Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Bellerophon Therapeutics (United States) | Researchclopedia

Back to institutions

Bellerophon Therapeutics (United States)

Warrencompany

22

Works

1,063

Citations

15

h-index

Top Research Topics

Pulmonary Hypertension Research and Treatments Chronic Obstructive Pulmonary Disease (COPD) Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Top Researchers

Howard Levy Mayo Clinic in Arizona

183 works9,516 citationsh-index: 48

Recent Research

Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial

Olivier Sitbon,Andris Skride,et al.

202415 citations

Medical Imaging and Pathology Studies

Heart Failure Treatment and Management

Cardiac Valve Diseases and Treatments

Cardiovascular and exercise physiology

Atomic and Subatomic Physics Research

Tissue Engineering and Regenerative Medicine

Cardiac Structural Anomalies and Repair

Respiratory Support and Mechanisms

Orthopaedic implants and arthroplasty

Douglas A. Greene Manitoba Health

95 works7,451 citationsh-index: 46

Deborah A. Quinn Johnson & Johnson (United States)

93 works7,171 citationsh-index: 36

Bo Kim Harvard University

198 works2,988 citationsh-index: 32

Hunter Gillies NKT Therapeutics (United States)

68 works2,929 citationsh-index: 21

Martin D. Meglasson

51 works2,166 citationsh-index: 25

Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-Blind, Placebo-controlled Trial

Steven D. Nathan,Natasa Rajicic,et al.

20244 citations

Inhaled Nitric Oxide in Fibrotic Lung Disease: A Randomized, Double-blind, Placebo-controlled Trial

Steven D. Nathan,Natasa Rajicic,et al.

20241 citations

Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

Steven D. Nathan,Peter Fernandes,et al.

202215 citations

Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension

Sylvia Nikkho,Manuel J. Richter,et al.

202257 citations

A Phase 2 Trial of INOpulse in Patients with Sarcoidosis Associated Pulmonary Hypertension (SAPH) Requiring Supplemental Oxygen

Ed Parsley,R.P. Baughman,et al.

20221 citations